3.4 Data on mammalian toxicity (Procedure (G9), paragraph 4.2.1.2)
Clasification Society 2024 - Version 9.40
Statutory Documents - IMO Publications and Documents - Circulars - Ballast Water Management - BWM.2/Circular.37 – International Convention for the Control and Management of Ships' Ballast Water and Sediments, 2004 – (14 June 2012)... - Annex – Information that should be made available in the Applications for Approval in accordance with Paragraph 8 of the Procedure for Approval of BWM Systems that make use of Active Substances (G9) (The Non-Confidential Information to be Submitted to MEPC) - 3 Application Data Set - 3.4 Data on mammalian toxicity (Procedure (G9), paragraph 4.2.1.2)

3.4 Data on mammalian toxicity (Procedure (G9), paragraph 4.2.1.2)

3.4.1 General

For proprietary experimental data the applied test method should be specified.
For each toxicological endpoint, the quality of the available data and the implications of the results should be briefly discussed.

3.4.2 Acute toxicity

Lethal or limit dose information, exposure route, species.

3.4.3 Effects on skin and eye

Application form/concentration tested, severity and reversibility of effect, species or in vitro model.
If tests have not been carried out on account of extreme pH or known or suspected corrosive properties this should be clearly stated and supporting information provided.

3.4.4 Repeated-dose toxicity

NOAEL or LOAEL, dose range tested, most sensitive effect observed (target organ), test duration, exposure route, species, and sex.

3.4.5 Chronic toxicity

NOAEL or LOAEL, dose range tested, most sensitive effect observed (target organ), test duration, exposure route, species, and sex.

3.4.6 Developmental and reproductive toxicity

NOAEL or LOAEL for systemic parental toxicity, effects on reproduction, and developmental effects, dose range tested, most sensitive effect observed, test duration, exposure route, and species.

3.4.7 Carcinogenicity

NOAEL or LOAEL for tumour and non-tumour effects, dose range tested, most sensitive effect observed, test duration, exposure route, species, and sex.
If available carcinogenicity classifications are cited, a full verbal description of the relevant classification should be provided as well as the year of the last assessment. It is not appropriate to cite carcinogenicity classifications that have been outdated by more recent relevant experimental data.

3.4.8 Mutagenicity/Genotoxicity

Experimental model, dose range tested.

3.4.9 Toxicokinetics


Copyright 2022 Clasifications Register Group Limited, International Maritime Organization, International Labour Organization or Maritime and Coastguard Agency. All rights reserved. Clasifications Register Group Limited, its affiliates and subsidiaries and their respective officers, employees or agents are, individually and collectively, referred to in this clause as 'Clasifications Register'. Clasifications Register assumes no responsibility and shall not be liable to any person for any loss, damage or expense caused by reliance on the information or advice in this document or howsoever provided, unless that person has signed a contract with the relevant Clasifications Register entity for the provision of this information or advice and in that case any responsibility or liability is exclusively on the terms and conditions set out in that contract.